
Hongcheng Zhu/X
Mar 25, 2025, 18:29
Hongcheng Zhu: Multidisciplinary management of N2 stage III NSCLC
Hongcheng Zhu, Radiation and Clinical Oncologist at Fudan University Shanghai Cancer Center, shared a post on X:
“It was a year ago at ELCC24 in Prague, when I have an opportunity to meet the panel of multidisciplinary group exploring management of N2 NSCLC. Now our review finally out before ELCC25!
Really looking forward the inspirations in Paris this year!”
More posts featuring ELCC24.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 28, 2025, 17:15
Mar 28, 2025, 17:05
Mar 28, 2025, 16:56
Mar 28, 2025, 15:54